ERBB2 and breast cancer: The proportion of TILs as a continuous variable has proven to be an independent prognostic biomarker in early-stage ERBB2/HER2-positive breast cancer.13,14,15,16,17,18 Thus, the evaluation of TILs has been proposed as a readily available tool to identify different prognostic groups in this setting.